Predicting postnatal circulation in pulmonary atresia with intact ventricular septum
Official title: Development and Validation of a Prognostic Model of Postnatal Circulation in Fetuses With a Diagnosis of Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum A Prospective Observational Cohort Study
Run by Hospital Universitario 12 de Octubre · NCT07095829 · Data updated 2026-11-12
This project will try to use fetal ultrasound measurements to see if doctors can predict which babies with pulmonary atresia and an intact ventricular septum will have a biventricular/one-and-a-half repair versus need univentricular palliation by age 2.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Weeks to 28 Weeks |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | Hospital Universitario 12 de Octubre Academic / other |
| Locations | 2 sites (Madrid and 1 other locations) |
| Status | Recruiting |
| Started | February 1, 2024 |
| Main results expected | February 1, 2028 |
| Study ends | December 31, 2029 |
| Registry record updated | September 15, 2025 |
| Trial ID | NCT07095829 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are fetuses diagnosed at a participating referral center between 16+0 and 28+6 weeks with pulmonary atresia or critical pulmonary stenosis and an intact ventricular septum, without major extracardiac anomalies or known genetic syndromes, and who did not undergo prenatal pulmonary valvuloplasty.
✕Probably not a fit
Patients who had prenatal pulmonary valvuloplasty, terminated pregnancies, poor-quality or incomplete imaging, postnatally unconfirmed diagnoses, or significant associated cardiac or extracardiac anomalies are unlikely to benefit from or be included in the predictive model.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an international observational cohort that combines retrospective cases (2013–2023) with a prospective validation cohort to develop a prenatal prognostic model. Non-intervened fetuses diagnosed between 16+0 and 28+6 weeks with PA/CS-IVS will be included and baseline and follow-up fetal echocardiograms plus the first postnatal echo will be collected. All echocardiographic studies will be reviewed centrally by a core laboratory to confirm eligibility and standardize measurements. The primary outcome is transplantation-free survival with a biventricular or one-and-a-half repair at 2 years versus univentricular palliation or transplantation, and the study will also model risk of right-ventricle-dependent coronary circulation.
Why it matters
Potential benefit: If successful, the model could give families and clinicians clearer prenatal prognoses to guide counseling, delivery planning, and early postnatal management.
How similar studies have gone: There are single-center reports and surgical series describing outcomes and some predictors, but comprehensive, externally validated prenatal models for predicting univentricular versus biventricular circulation in PA/CS-IVS remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Absence of flow at the pulmonary valve (PA) or presence of thickened and domed. pulmonary valve cusps with a pinhole jet of flow. * Doppler evidence of ductal-dependent pulmonary circulation. * Intact ventricular septum. Exclusion Criteria: * Poor imaging windows and incomplete/poor quality scan * Termination of pregnancy * Cases initially included that undergo prenatal pulmonary valvuloplasty later on in pregnancy. * Unconfirmed PA-CS/IVS at birth. * Functional PA-CS/IVS (Ebstein malformation, monochorionic twins) * Any associated cardiac defect except persistent left superior vena cava and aberrant right subclavian artery. * Any significant (i.e that might influence outcome) extracardiac anomaly and/or known genetic syndromes. Also, if such a condition is present at inclusion but diagnosed only after birth, the case will be retrospectively excluded.
Where it's running
-
Hospital Universitario 12 de Octubre
Madrid, Spain Recruiting -
University of Gothenburg
Gothenburg, Sweden Active not recruiting
Study contacts
- Principal investigator: Cecilia Villalaín González, MD PhD — Instituto de investigación imas12
- Study coordinator: Cecilia Villalain, MD PhD
- Email: cecilia.villalain@salud.madrid.org
- Phone: +34913908310
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating fetal aortic valve balloon dilation for congenital heart defects
This study is testing whether a procedure called fetal aortic valvuloplasty can help fetuses with aortic valve problems caused by hypoplastic left heart syndrome feel better and have better outcomes.
-
Monitoring fetal heart activity in high-risk pregnancies to prevent stillbirth
This study is testing a new way to monitor fetal heart activity in high-risk pregnancies to see if it can help prevent stillbirth.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.